6 studies found for:    EXT2
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019 EXT2)
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: Comparator: placebo
2 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: Comparator: Placebo
3 Active, not recruiting
Has Results
A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004 AM2; EXT1(AM1); EXT2(AM2); EXT3)
Condition: Osteoporosis
Interventions: Drug: MK0822;   Dietary Supplement: Vitamin D3;   Dietary Supplement: Calcium Carbonate;   Drug: Placebo
4 Terminated An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
Condition: Uterine Fibroids
Intervention: Drug: Proellex®
5 Terminated
Has Results
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)
Conditions: Lung Diseases;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: MK-0873 2.5 mg;   Drug: MK-0873 1.25 mg;   Drug: MK-0873 0.75 mg;   Drug: Placebo to MK-0873;   Drug: Usual Care
6 Enrolling by invitation An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Condition: Schizophrenia
Interventions: Drug: ALKS 9072, Low Dose;   Drug: ALKS 9072, High Dose

Indicates status has not been verified in more than two years